Phreesia’s Danielle Lynch Named a ‘Sales MVP’ in PM360’s ELITE 100
ncarol.com/10173556

RALEIGH, N.C.--(BUSINESS WIRE)--Phreesia is pleased to announce that the healthcare marketing industry trade publication PM360 has named Danielle Lynch, Vice President, Client Experience, as one of the 2022 PM360 ELITE 100.

The PM360 ELITE Awards recognize the most influential people in the healthcare and life sciences industry today, and honorees were chosen from a pool of more than 500 submissions across 20 categories. The PM360 editorial staff selected winners based on their career accomplishments and the influence they've had on the industry.

Lynch was named in the "Sales MVPs" category, honoring leaders who are doing an outstanding job of building revenue and forming relationships that add to the growth of their company. Since helping Phreesia go public in 2019, Lynch has played a pivotal role in more than doubling the size of her Client Experience team and its bookings.

More on ncarol.com

• FDA-Cleared Zeta TMS Robotic System Moves Toward Deployment as FDA, DARPA and Commercial Catalysts Converge: NRx Pharmaceuticals (N A S D A Q: NRXP)
• Baird Medical Turns Global Expansion Into Tangible Growth: N A S D A Q: BDMD Posts 25% Revenue Surge as U.S. and International Markets Accelerate
• Black Mountain Meets "Human Error": KayeDinero on What Technology Can't Reproduce
• As Brevard Heads Into Mountain Song Weekend, KayeDinero Brings a Different Kind of WNC Sound
• Why Did KayeDinero Put Haywood Road Into a Song?

"I'm honored to be recognized by PM360, and I'm incredibly proud of the way the Client Experience team has contributed to the growth and success of Phreesia Life Sciences over the past few years," Lynch said.

Lynch has created a positive, collaborative culture through her team-based sales model, which operates without individual contributors and instead brings in talent from creative and media agency backgrounds who have worked on a wide range of brands, therapeutic categories and life cycles to achieve its quotas. Under her leadership, the Client Experience team has grown business across almost all of its accounts, and Phreesia's Life Sciences revenue has increased significantly, with approximately 77% expansion during fiscal year 2022.

"We are thrilled to see Danielle awarded this well-deserved honor," said David Linetsky, Phreesia's Senior Vice President, Life Sciences. "Her innovative approach to team building and client partnership are radically different than anything I've seen in other organizations. And despite rapidly scaling, she has managed to maintain the incredible team culture she pioneered to attract and retain some of the absolute best talent in the industry."

More on ncarol.com

• Shelter Structures America makes European debut at TEMPOR EXPO 2026 in Fulda, Germany
• TekTone innovation meets patient care
• HydroExcavation.com Relaunches With Exclusive Local Service Areas and Dedicated Hydrovac Manufacturer Directory
• Sky Quarry Enters a Powerful New Chapter: Refinery Restart Emminent, Nevada Oil Initiative and Visibility Put (NAS DAQ: SKYQ) in the Spotlight
• OneVizion Launches Vera AI, Bringing Connected Operational Context to Infrastructure Teams

About Phreesia Life Sciences

Phreesia empowers life sciences companies to connect meaningfully with clinically relevant patients, delivering targeted health content in a one-to-one setting. Our PatientConnect offering identifies and motivates the right patients to initiate meaningful brand conversations, and our PatientInsights product enables our clients to better understand their target patient populations.

Phreesia meets patients where they are, both virtually and in-person, and reaches them at multiple touchpoints throughout their healthcare journey. To learn more about Phreesia Life Sciences, visit lifesciences.phreesia.com.

Contacts

Media:
Carly Helfand
chelfand@phreesia.com
332-910-6768

---

Show All News | Disclaimer | Report Violation